New methods of preclinical testing of tiludronate, a drug for use in the prevention or treatment of postmenopausal osteoporosis and paget’s disease of bone
A. Barbier, C. Martel, F. Lacheretz, Sanofi RechercheVolume:
6
Year:
1996
Language:
english
Pages:
1
DOI:
10.1007/bf02500594
File:
PDF, 136 KB
english, 1996